Skip to main content
Premium Trial:

Request an Annual Quote

Celera Stock Sale Nets $983 M to Fund Product, Technology Development

Premium

R

OCKVILLE, Md.--Celera Genomics received $983.25 million from the March 3 sale of 4.37 million shares of its stock, the Washington Post reported. The net proceeds from the offering are intended primarily to fund Celera’s new product and technology development activities in functional genomics, with an emphasis on proteomics and personalized health/medicine. Proceeds might also be used for acquisitions, alliances, or collaborations.

Filed under

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.